European breast cancer service screening outcomes: a first balance sheet of the benefits and harms
- PMID:24991022
- DOI: 10.1158/1055-9965.EPI-13-0320
European breast cancer service screening outcomes: a first balance sheet of the benefits and harms
Abstract
A recent comprehensive review has been carried out to quantify the benefits and harms of the European population-based mammographic screening programs. Five literature reviews were conducted on the basis of the observational published studies evaluating breast cancer mortality reduction, breast cancer overdiagnosis, and false-positive results. On the basis of the studies reviewed, the authors present a first estimate of the benefit and harm balance sheet. For every 1,000 women screened biennially from ages 50 to 51 years until ages 68 to 69 years and followed up until age 79 years, an estimated seven to nine breast cancer deaths are avoided, four cases are overdiagnosed, 170 women have at least one recall followed by noninvasive assessment with a negative result, and 30 women have at least one recall followed by invasive procedures yielding a negative result. The chance of a breast cancer death being avoided by population-based mammography screening of appropriate quality is more than that of overdiagnosis by screening. These outcomes should be communicated to women offered service screening in Europe.
©2014 American Association for Cancer Research.
Similar articles
- Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet.Paci E; EUROSCREEN Working Group.Paci E, et al.J Med Screen. 2012;19 Suppl 1:5-13. doi: 10.1258/jms.2012.012077.J Med Screen. 2012.PMID:22972806
- The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.Broeders M, Paci E.Broeders M, et al.Womens Health (Lond). 2015 Nov;11(6):883-90. doi: 10.2217/whe.15.34. Epub 2015 Nov 30.Womens Health (Lond). 2015.PMID:26619214
- Benefit-to-harm ratio of the Danish breast cancer screening programme.Beau AB, Lynge E, Njor SH, Vejborg I, Lophaven SN.Beau AB, et al.Int J Cancer. 2017 Aug 1;141(3):512-518. doi: 10.1002/ijc.30758. Epub 2017 May 10.Int J Cancer. 2017.PMID:28470685Free PMC article.
- Benefits and harms of mammography screening.Løberg M, Lousdal ML, Bretthauer M, Kalager M.Løberg M, et al.Breast Cancer Res. 2015 May 1;17(1):63. doi: 10.1186/s13058-015-0525-z.Breast Cancer Res. 2015.PMID:25928287Free PMC article.Review.
- Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.Njor S, Nyström L, Moss S, Paci E, Broeders M, Segnan N, Lynge E; Euroscreen Working Group.Njor S, et al.J Med Screen. 2012;19 Suppl 1:33-41. doi: 10.1258/jms.2012.012080.J Med Screen. 2012.PMID:22972809Review.
Cited by
- A CNN Hyperparameters Optimization Based on Particle Swarm Optimization for Mammography Breast Cancer Classification.Aguerchi K, Jabrane Y, Habba M, El Hassani AH.Aguerchi K, et al.J Imaging. 2024 Jan 24;10(2):30. doi: 10.3390/jimaging10020030.J Imaging. 2024.PMID:38392079Free PMC article.
- Personalized Breast Cancer Screening: A Risk Prediction Model Based on Women Attending BreastScreen Norway.Louro J, Román M, Moshina N, Olstad CF, Larsen M, Sagstad S, Castells X, Hofvind S.Louro J, et al.Cancers (Basel). 2023 Sep 12;15(18):4517. doi: 10.3390/cancers15184517.Cancers (Basel). 2023.PMID:37760486Free PMC article.
- Tendency to Breast Cancer Screening Among Rural Women in Southern Iran: A Structural Equation Modeling (SEM) Analysis of Theory of Planned Behavior.Keshavarzi A, Asadi S, Asadollahi A, Mohammadkhah F, Khani Jeihooni A.Keshavarzi A, et al.Breast Cancer (Auckl). 2022 Sep 6;16:11782234221121001. doi: 10.1177/11782234221121001. eCollection 2022.Breast Cancer (Auckl). 2022.PMID:36091183Free PMC article.
- Modeling Radiologists' Assessments to Explore Pairing Strategies for Optimized Double Reading of Screening Mammograms.Gommers JJJ, Abbey CK, Strand F, Taylor-Phillips S, Jenkinson DJ, Larsen M, Hofvind S, Broeders MJM, Sechopoulos I.Gommers JJJ, et al.Med Decis Making. 2024 Oct;44(7):828-842. doi: 10.1177/0272989X241264572. Epub 2024 Jul 30.Med Decis Making. 2024.PMID:39077968Free PMC article.
- Overdiagnosis of breast cancer in population screening: does it make breast screening worthless?Houssami N.Houssami N.Cancer Biol Med. 2017 Feb;14(1):1-8. doi: 10.20892/j.issn.2095-3941.2016.0050.Cancer Biol Med. 2017.PMID:28443199Free PMC article.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical